Enovix (ENVX) Current Deferred Revenue (2020 - 2025)
Historic Current Deferred Revenue for Enovix (ENVX) over the last 6 years, with Q3 2025 value amounting to $8.0 million.
- Enovix's Current Deferred Revenue fell 2000.0% to $8.0 million in Q3 2025 from the same period last year, while for Sep 2025 it was $8.0 million, marking a year-over-year decrease of 2000.0%. This contributed to the annual value of $3.6 million for FY2024, which is 6517.84% down from last year.
- Enovix's Current Deferred Revenue amounted to $8.0 million in Q3 2025, which was down 2000.0% from $8.4 million recorded in Q2 2025.
- In the past 5 years, Enovix's Current Deferred Revenue ranged from a high of $10.8 million in Q2 2024 and a low of $2.9 million during Q3 2022
- In the last 5 years, Enovix's Current Deferred Revenue had a median value of $5.6 million in 2022 and averaged $6.4 million.
- Examining YoY changes over the last 5 years, Enovix's Current Deferred Revenue showed a top increase of 18421.05% in 2024 and a maximum decrease of 6517.84% in 2024.
- Over the past 5 years, Enovix's Current Deferred Revenue (Quarter) stood at $5.5 million in 2021, then fell by 21.75% to $4.3 million in 2022, then skyrocketed by 143.77% to $10.5 million in 2023, then crashed by 65.18% to $3.6 million in 2024, then surged by 119.18% to $8.0 million in 2025.
- Its Current Deferred Revenue was $8.0 million in Q3 2025, compared to $8.4 million in Q2 2025 and $6.9 million in Q1 2025.